Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹9.04 Cr₹41 Cr₹-60 Cr₹-73 Cr₹-108 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS is ₹9.04 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹9.04 Cr
Mar2024₹41 Cr
Mar2023₹-60 Cr
Mar2022₹-73 Cr
Mar2021₹-108 Cr

How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹9.04 Cr
-77.74
Mar2024 ₹41 Cr
Positive
Mar2023 ₹-60 Cr
Negative
Mar2022 ₹-73 Cr
Negative
Mar2021 ₹-108 Cr -

Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹34,869.7 Cr 4.9% 5.8% 35.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,803.0 Cr 2.8% 1.8% 13.4% Stock Analytics
DIVIS LABORATORIES ₹179,219.0 Cr -0.2% -0.1% 3.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,417.0 Cr 1.4% -1.5% 39.9% Stock Analytics
CIPLA ₹116,116.0 Cr 6% 1.7% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,874.0 Cr 4.8% -0.3% -0.9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

4.9%

5.8%

35.6%

SENSEX

-0.2%

2.1%

-5.6%


You may also like the below Video Courses